Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study

Biological Psychiatry

Volumn 43, Issue 9, 1998, Pages 641-648

  Bertolino, Alessandro ^a   Callicott, Joseph H ^a   Elman, Igor ^b   Mattay, Venkata S ^a   Tedeschi, Gioacchino ^c   Frank, Joseph A ^d   Breier, Alan ^b   Weinberger, Daniel R ^a  

^a Clinical Brain Disorders Branch   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NINDS   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

1H magnetic resonance spectroscopic imaging; Drug treatment; Hipocampal area; N acetyl aspartate; Prefrontal cortex; Schizophrenia

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NEUROPATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA;

ADULT; ASPARTIC ACID; BRAIN; BRAIN CHEMISTRY; CHOLINE; CREATINE; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURONS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0032079453     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00555-6     Document Type: Article

References (42)

1. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia. Arch Gen Psychiatry. 52:1995;341-351.
2. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P. A longitudinal study of symptom dimensions in schizophrenia. Arch Gen Psychiatry. 52:1995;352-360.
3. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the enthorinal cortex in schizophrenia. Arch Gen Psychiatry. 48:1991;625-632.
4. Barker PB, Breiter SN, Soher BJ, Chatham JC, Forder JR, Samphilipo MA, et al. Quantitative proton spectroscopy of canine brain In vivo and in vitro correlations . Magn Reson Med. 32:1994;157-163.
5. Benes FM, Davidson B, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 43:1986;31-35.
6. Bertolino A, Nawroz S, Mattay VS, Duyn JH, Moonen CTW, Barnett AS, et al. A specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
7. Bertolino A, Callicott JH, Nawroz S, Mattay VS, Duyn JH, Tedeschi G, et al. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology. 18:1998;1-9.
8. Bertolino A, Saunders RC, Mattay VS, Duyn JH, Bachevalier J, Frank JA, et al. Multislice proton magnetic resonance spectroscopic imaging in monkeys with mesial temporo-limbic lesions. Cereb Cortex. 7:1997;740-748.
9. Brenner RE, Munro PMG, Williams SCR, Bell JD, Barker GJ, Hawkins CP, et al. The proton NMR spectrum in acute EAE The significance of the change in the Cho:Cre ratio . Magn Reson Med. 29:1993;737-745.
10. 1H-Magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia Clinical, neurodevelopmental, and cognitive correlates . Biol Psychiatry. 36:1994;792-800.
11. 1H-MRSI abnormalities in unaffected siblings of patients with schizophrenia Possible genetic markers . Neuroimage. 5:1997;282.
12. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 44:1994;1411-1417.
13. De Stefano N, Matthews P, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlations with disability. Ann Neurol. 38:1995;901-909.
14. Duvernoy HM, Cabanis EA. The Human Brain Surface, Three-Dimensional Sectional Anatomy, and MRI . 1991;Springer-Verlag, New York.
15. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CTW. Multisection proton MR spectroscopic imaging of the brain. Radiology. 188:1993;277-282.
16. Falconer JC, Liu S-J, Abbe RA, Narayana PA. Time dependence of N-acetyl-aspartate, lactate, and pyruvate concentrations following spinal cord injury. J Neurochem. 66:1996;717-722.
17. Falkai P, Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 236:1986;154-161.
18. First MB, Gibbon M, Spitzer RL, Williams JBW. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version. 1996;New York State Psychiatric Institute, Biometrics Research, New York.
19. Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, et al. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia Preliminary report . Psychiatry Res Neuroimaging. 61:1995;193-200.
20. 1H Magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand Suppl. 152:1994;116-121.
21. Hetherington H, Kuzniecky R, Pan J, Mason G, Morawetz R, Harris C, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol. 38:1995;396-404.
22. Hollingshead A, Frederick RC. Social stratification and psychiatric disorders. Am Soc Rev. 18:1953;163-169.
23. Hugg JW, Kuzniecky RI, Gilliam FG, Morawetz RB, Faught RE, Hetherington HP. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol. 40:1996;236-239.
24. Jakob H, Beckman H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm. 65:1989;303-326.
25. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia A morphometric study . Arch Gen Psychiatry. 46:1989;1019-1024.
26. Lieberman JA. Signs and symptoms. What can they tell us about the clinical course and pathophysiologic process of schizophrenia? Arch Gen Psychiatry. 52:1995;361-363.
27. Maier M, Ron MA. Hippocampal age-related changes in schizophrenia A proton magnetic resonance spectroscopy study . Schizophr Res. 22:1996;5-17.
28. Maier M, Ron MA, Barker GJ, Tofts PS. Proton magnetic resonance spectroscopy An in vivo method of estimating hippocampal neuronal depletion in schizophrenia . Psychol Med. 25:1995;1201-1209.
29. Miller BL. A review of chemical issues in 1H NMR spectroscopy N-Acetyl-L-aspartate, creatine and choline . NMR Biomed. 4:1991;47-52.
30. Nasrallah HA, Skinner TE, Schmalbrock P, Robitaille PM. Proton magnetic resonance spectroscopy of the hippocampal formation in schizophrenia A pilot study . Br J Psychiatry. 165:1994;481-485.
31. Ng TC, Comair YG, Xue M, So N, Majors A, Kolem H, et al. Temporal lobe epilepsy Presurgical localization with proton chemical shift imaging . Radiology. 193:1994;4654-4672.
32. Okumura N, Otsuki S, Nasu H. The influence of insulin hypoglycaemic coma, repeated electroshocks, and chlorpromazine or beta-phenylisopropylmethylamine administration on the free amino acids in the brain. J Biochem. 46:1959;247-252.
33. Paul CR, Lenkinski RE, Boyko OB, Gur RE, Gur RC, Cecil K (1996): Proton magnetic resonance spectroscopy of patients with first episode of schizophrenia. In: International Society for Magnetic Resonance in Medicine, New York, Book of Abstracts. p 1001.
34. 1H magnetic resonance spectroscopy study . Magn Reson Med. 33:1995;595-600.
35. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry. 152:1995;444-446.
36. Roberts GW, Royston MC, Weinberger DR. Schizophrenia. Graham D, Lantos P. Greenfield's Neuropathology. 6th ed. 1997;897-930 Edward Arnold Ltd, London.
37. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 52:1995;805-818.
38. Sharma R, Venkatasubramanian PN, Barany M, Davis JM. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res. 8:1992;43-49.
39. Talaraich J, Tournoux P. A Co-Planar Stereotaxic Atlas of a Human Brain. 1988;Thieme, Stuttgart, Germany.
40. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 13:1993;981-989.
41. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone P. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet. 345:1995;60-61.
42. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Waternaux CM, Cohen BM. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res. 19:1996;55-59.